Search research articles

Katrin Mestermann

5PUBLICATIONS

15CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Nov 26, 2024

Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors.

Katrin Mestermann, Andoni Garitano-Trojaola, Michael Hudecek

|Feb 21, 2024

Correction: ROR1-targeting switchable CAR-T cells for cancer therapy.

Haiyong Peng, Thomas Nerreter, Katrin Mestermann

|Jul 21, 2022

ROR1-targeting switchable CAR-T cells for cancer therapy.

Haiyong Peng, Thomas Nerreter, Katrin Mestermann

|Jul 21, 2021

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia.

Hardikkumar Jetani, Almudena Navarro-Bailón, Marius Maucher

|Jul 05, 2019

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells.

Katrin Mestermann, Theodoros Giavridis, Justus Weber

Pageof 1

Frequent Collaborators

2 joint publications

Silke Frenz

2 joint publications

Michael Hudecek

2 joint publications

Christoph Rader

2 joint publications

Jing Chang

2 joint publications

Haiyong Peng

1 joint publications

Thomas Nerreter

1 joint publications

Andreas Mades

1 joint publications

Michel Sadelain

1 joint publications

Hardikkumar Jetani

1 joint publications

Marius Maucher

Frequent Collaborators

2 joint publications

Silke Frenz

2 joint publications

Michael Hudecek

2 joint publications

Christoph Rader

2 joint publications

Jing Chang

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Top Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

See more related videos

Top Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

See more related videos